TRENTON, New Jersey (AP) — French drugmaker Sanofi SA said Thursday that next spring it will begin selling a generic version in France of Pfizer's Lipitor, the cholesterol fighter that's the world's top-selling drug at nearly $11 billion a year.
Sanofi confirmed that its affiliate, Sanofi France, has signed a license with Pfizer to manufacture the drug, known generically as atorvastatin. The deal only allows sales within France.
Sanofi said it won't start sales until the drug's patent in France expires, on May 7, 2012.
A Pfizer spokesman noted no companies are authorized to sell generic Lipitor in France before then, but he provided no details on the deal. Sanofi …
No comments:
Post a Comment